デフォルト表紙
市場調査レポート
商品コード
524443

主要7カ国の動脈瘤性クモ膜下出血 (aSAH) :疫学的予測

Aneurysmal Subarachnoid Hemorrhage (aSAH) - Epidemiology Forecast - 2030

出版日: 受注後作成 | 発行: DelveInsight Business Research LLP | ページ情報: 英文 100 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.93円
主要7カ国の動脈瘤性クモ膜下出血 (aSAH) :疫学的予測
出版日: 受注後作成
発行: DelveInsight Business Research LLP
ページ情報: 英文 100 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、主要7カ国における動脈瘤性クモ膜下出血 (aSAH) の発生動向を調査し、疾患の背景、臨床症状、リスク要因、病態生理、主要7カ国 (米国・ドイツ・フランス・イタリア・スペイン・英国・日本) における発生数の推移と予測、グレード・性別などによる内訳、アンメットニーズの分析などをまとめています。

第1章 重要考察

第2章 疾患の背景・概要:動脈瘤性クモ膜下出血 (aSAH)

  • イントロダクション
  • 症状
  • 病因・リスク要因
  • グレード区分
  • 病態生理
  • 診断
  • バイオマーカー
  • 管理

第3章 疫学・患者人口

  • 主要調査結果

第4章 主要7カ国のaSAH発生数

第5章 aSAHの疫学:国別

  • 米国
    • 総発生数
    • 発生数:男女別
    • 発生数:グレード別
    • 診断症例数
  • EU5カ国
    • ドイツ
    • フランス
    • イタリア
    • スぺイン
    • 英国
      • 総発生数
      • 発生数:男女別
      • 発生数:グレード別
      • 診断症例数
  • 日本
    • 総発生数
    • 発生数:男女別
    • 発生数:グレード別
    • 診断症例数

第6章 アンメットニーズ

第7章 付録

第8章 DelveInsightの能力

第9章 免責事項

第10章 DelveInsightについて

図表

List of Tables

  • Table 1: Summary of Aneurysmal Subarachnoid Hemorrhage (aSAH), Epidemiology and Key Events (2017-2030)
  • Table 2: Risk Factors for the Formation of and Rupture of Intracranial Aneurysms
  • Table 3: Clinical Features of Intracranial Aneurysms Based on Location
  • Table 4: Hunt and Hess scale
  • Table 5: Incidence of Subarachnoid Hemorrhage (SAH) in the 7MM (2017-2030)
  • Table 6: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the 7MM (2017-2030)
  • Table 7: Incidence of Subarachnoid Hemorrhage (SAH) in the United States (2017-2030)
  • Table 8: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Table 9: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Table 10: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Table 11: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Table 12: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Table 13: Incidence of Subarachnoid Hemorrhage (SAH) in Germany (2017-2030)
  • Table 14: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Table 15: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Table 16: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Table 17: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Table 18: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Table 19: Incidence of Subarachnoid Hemorrhage (SAH) in France (2017-2030)
  • Table 20: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Table 21: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Table 22: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Table 23: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Table 24: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Table 25: Incidence of Subarachnoid Hemorrhage (SAH) in Italy (2017-2030)
  • Table 26: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Table 27: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Table 28: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Table 29: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Table 30: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Table 31: Incidence of Subarachnoid Hemorrhage (SAH) in Spain (2017-2030)
  • Table 32: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Table 33: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Table 34: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Table 35: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Table 36: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Table 37: Incidence of Subarachnoid Hemorrhage (SAH) in the United Kingdom (2017-2030)
  • Table 38: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Table 39: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Table 40: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Table 41: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Table 42: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Table 43: Incidence of Subarachnoid Hemorrhage (SAH) in Japan (2017-2030)
  • Table 44: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)
  • Table 45: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)
  • Table 46: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)
  • Table 47: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)
  • Table 48: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)

List of Figures

  • Figure 1: Aneurysmal subarachnoid hemorrhage SWOT Analysis
  • Figure 2: The intracranial arterial circulation showing the common locations of aneurysms.
  • Figure 3: Circle of Willis: The Circle of Willis is the joining area of several arteries at the bottom (inferior) side of the brain. At the Circle of Willis, the internal carotid arteries branch into smaller arteries that supply oxygenated blood to over 80% of the cerebrum.
  • Figure 4: Scale grading system used to quantify the amount of subarachnoid hemorrhage and intraventricular hemorrhage (IVH). The percentages in the circles refer to the risk of vasospasm. Grades III and IV in the scale are the ones with the higher risk to develop "symptomatic vasospasm."
  • Figure 5: Grading of SAH
  • Figure 6: Diagnostic Algorithm for Aneurysmal Subarachnoid Hemorrhage
  • Figure 7: CT scan for a SAH
  • Figure 8: Suggested scheme for diagnosing patients with suspected SAH
  • Figure 9: Incidence of Subarachnoid Hemorrhage (SAH) in the 7MM (2017-2030)
  • Figure 10: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the 7MM (2017-2030)
  • Figure 11: Incidence of Subarachnoid Hemorrhage (SAH) in the United States (2017-2030)
  • Figure 12: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Figure 13: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Figure 14: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Figure 15: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Figure 16: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States (2017-2030)
  • Figure 17: Incidence of Subarachnoid Hemorrhage (SAH) in Germany (2017-2030)
  • Figure 18: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Figure 19: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Figure 20: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Figure 21: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Figure 22: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany (2017-2030)
  • Figure 23: Incidence of Subarachnoid Hemorrhage (SAH) in France (2017-2030)
  • Figure 24: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Figure 25: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Figure 26: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Figure 27: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Figure 28: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France (2017-2030)
  • Figure 29: Incidence of Subarachnoid Hemorrhage (SAH) in Italy (2017-2030)
  • Figure 30: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Figure 31: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Figure 32: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Figure 33: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Figure 34: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy (2017-2030)
  • Figure 35: Incidence of Subarachnoid Hemorrhage (SAH) in Spain (2017-2030)
  • Figure 36: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Figure 37: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Figure 38: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Figure 39: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Figure 40: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain (2017-2030)
  • Figure 41: Incidence of Subarachnoid Hemorrhage (SAH) in the United Kingdom (2017-2030)
  • Figure 42: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Figure 43: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Figure 44: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Figure 45: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Figure 46: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom (2017-2030)
  • Figure 47: Incidence of Subarachnoid Hemorrhage (SAH) in Japan (2017-2030)
  • Figure 48: Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)
  • Figure 49: Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)
  • Figure 50: WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)
  • Figure 51: Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)
  • Figure 52: Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan (2017-2030)
目次
Product Code: DIEI0027

DelveInsight's 'Aneurysmal Subarachnoid Hemorrhage (aSAH) -Epidemiology Forecast-2030' report delivers an in-depth understanding of the disease, historical and forecasted Aneurysmal Subarachnoid Hemorrhage (aSAH) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Aneurysmal Subarachnoid Hemorrhage (aSAH) Understanding

Spontaneous (nontraumatic) subarachnoid hemorrhage (SAH) usually results from the rupture of a cerebral aneurysm. These aneurysms, which are located at the branching point of proximal intracranial arteries, are not uncommon and found in about 2% of the adult population (and even more frequently in those with a family history of a ruptured aneurysm or polycystic kidney disease). Aneurysmal SAH is a worldwide health burden with high fatality and permanent disability rates. It is defined, according to the standard criteria, as an abrupt onset of a severe headache and/or loss of consciousness, with or without focal neurological signs, with CT, necropsy, or lumbar puncture, evidence of focal or generalized blood in the subarachnoid space.

An aneurysm is often an incidental finding during investigations for other causes of intracranial pathology. Most aneurysms remain undetected during one's lifetime or until rupture. Aneurysms may present in several ways, such as headache, bilateral temporal hemianopsia, bilateral lower extremity weakness (anterior communicating artery aneurysm), facial or orbital pain, epistaxis, symptoms of brainstem dysfunction (posterior circulation aneurysms) and others.

Aneurysmal Subarachnoid Hemorrhage (aSAH) Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Incident Cases of Aneurysmal Subarachnoid Hemorrhage (aSAH), Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH), Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH), WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH), Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH), and Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) scenario of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan from 2017 to 2030. The additional segments include Gender-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) and Hunt-Hess Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH).

Aneurysmal Subarachnoid Hemorrhage (aSAH) Detailed Epidemiology Segmentation

  • In the 7MM, the total incident of Subarachnoid Hemorrhage (SAH) was estimated to be 63,072 cases in 2017 whereas the total incident of Aneurysmal Subarachnoid Hemorrhage (aSAH) was estimated to be 53,611.
  • According to the analysis, the estimated cases in WFNS grade-wise segmentation in 2017 for I-II, III, IV-V was 1,740, 305, and 1,196 respectively. The anticipated decrease in the grade wise segmentation in the forecast period is 1,393, 244 and 957 in Germany.
  • Several manifestations act as a contributor in course of development of aSAH. A total of 9,193, 3,940, 9,718, 10,112, 6,960 and 4,597 cases develop during aSAH i.e., Angiographic Vasospasm, Delayed ischemic neurologic deficit (DIND), Headache, Nausea or Vomiting, Loss of Conciousness and Nuchal Rigidity in 2017, which as per Delveinsight assessments will decrease to 8,391, 3,596, 8,870, 9,230, 6,353 and 4,195 cases, respectively, in 2030 in the US.
  • According to the analysis, the estimated cases in Fisher grade-wise segmentation in 2017 for I-II, III-IV is 468, and 1,930 respectively. The anticipated decrease in the grade wise segmentation in the forecast period is 374 and 1,545 (France).
  • The total incidence of Subarachnoid Hemorrhage (SAH) in the 7MM is expected to increase at a CAGR of 0.41% for the study period of 2017-2030.

Scope of the Report:

  • The report covers the descriptive overview of Aneurysmal Subarachnoid Hemorrhage (aSAH), explaining its causes, signs and symptoms, pathophysiology and currently available therapies.
  • The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of Aneurysmal Subarachnoid Hemorrhage (aSAH).
  • The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of Aneurysmal Subarachnoid Hemorrhage (aSAH), Total Diagnosed and Treated Cases of Aneurysmal Subarachnoid Hemorrhage (aSAH).

Report Highlights:

  • Eleven-Year Forecast of Aneurysmal Subarachnoid Hemorrhage (aSAH)
  • 7MM Coverage
  • Incident Cases of Aneurysmal Subarachnoid Hemorrhage (aSAH)
  • Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH)
  • Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH)
  • WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH)
  • Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH)
  • Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH)

Key Questions Answered

  • What is the disease risk, burden and unmet needs of Aneurysmal Subarachnoid Hemorrhage (aSAH)?
  • What is the historical Aneurysmal Subarachnoid Hemorrhage (aSAH) patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?
  • What would be the forecasted patient pool of Aneurysmal Subarachnoid Hemorrhage (aSAH) at the 7MM level?
  • What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Aneurysmal Subarachnoid Hemorrhage (aSAH)?
  • Out of the above-mentioned countries, which country would have the highest incident population of Aneurysmal Subarachnoid Hemorrhage (aSAH) during the forecast period (2020-2030)?
  • At what CAGR the population is expected to grow across the 7MM during the forecast period (2020-2030)? 

Reasons to buy:

The Aneurysmal Subarachnoid Hemorrhage (aSAH) report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the 7MM Aneurysmal Subarachnoid Hemorrhage (aSAH) market.
  • Quantify patient populations in the 7MM Aneurysmal Subarachnoid Hemorrhage (aSAH).
  • The Aneurysmal Subarachnoid Hemorrhage (aSAH) epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
  • The Aneurysmal Subarachnoid Hemorrhage (aSAH) epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the eleven-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1 Key Insights

2 Executive Summary

3 SWOT Analysis

4 Aneurysmal Subarachnoid Hemorrhage (aSAH) Epidemiology Overview at a Glance

5 Disease Background and Overview: Aneurysmal Subarachnoid Hemorrhage

  • 5.1 Introduction
  • 5.2 Risk Factors
  • 5.3 Clinical Presentation
    • 5.3.1 Cardiac Manifestations
    • 5.3.2 Neurogenic Pulmonary Edema (NPE)
    • 5.3.3 Hypertension
  • 5.4 Grading
    • 5.4.1 World Federation of Neurosurgeons SAH Scale (WFNS)
    • 5.4.2 The Hunt and Hess Scale
    • 5.4.3 Fisher Scale
  • 5.5 Pathophysiology
  • 5.6 Diagnosis
    • 5.6.1 Computerized tomography (CT scan)
    • 5.6.2 Lumbar puncture
    • 5.6.3 Magnetic resonance imaging (MRI)
    • 5.6.4 Aneurysm detection
  • 5.7 Management
    • 5.7.1 Acute Management
    • 5.7.2 Management of the ruptured aneurysm
    • 5.7.3 Rebleeding
    • 5.7.4 Critical care management
    • 5.7.5 DCI and vasospasm

6 Recognized Establishments

7 Epidemiology and Patient Population

  • 7.1 Key Findings
  • 7.2 7 Major Markets Epidemiology
    • 7.2.1 Incidence of Subarachnoid Hemorrhage (SAH) in the 7MM
    • 7.2.2 Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the 7MM
  • 7.3 United States
    • 7.3.1 Assumption and Rationale
    • 7.3.2 Incidence of Subarachnoid Hemorrhage (SAH) in the United States
    • 7.3.3 Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States
    • 7.3.4 Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States
    • 7.3.5 WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States
    • 7.3.6 Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States
    • 7.3.7 Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United States
  • 7.4 EU-5 Epidemiology
    • 7.4.1 Assumption and rationale
  • 7.5 Germany
    • 7.5.1 Incidence of Subarachnoid Hemorrhage (SAH) in Germany
    • 7.5.2 Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the Germany
    • 7.5.3 Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the Germany
    • 7.5.4 WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany
    • 7.5.5 Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany
    • 7.5.6 Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Germany
  • 7.6 France
    • 7.6.1 Incidence of Subarachnoid Hemorrhage (SAH) in France
    • 7.6.2 Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France
    • 7.6.3 Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France
    • 7.6.4 WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France
    • 7.6.5 Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France
    • 7.6.6 Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in France
  • 7.7 Italy
    • 7.7.1 Incidence of Subarachnoid Hemorrhage (SAH) in Italy
    • 7.7.2 Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy
    • 7.7.3 Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy
    • 7.7.4 WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy
    • 7.7.5 Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy
    • 7.7.6 Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Italy
  • 7.8 Spain
    • 7.8.1 Incidence of Subarachnoid Hemorrhage (SAH) in Spain
    • 7.8.2 Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain
    • 7.8.3 Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain
    • 7.8.4 WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain
    • 7.8.5 Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain
    • 7.8.6 Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Spain
  • 7.9 United Kingdom
    • 7.9.1 Incidence of Subarachnoid Hemorrhage (SAH) in the United Kingdom
    • 7.9.2 Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom
    • 7.9.3 Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom
    • 7.9.4 WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom
    • 7.9.5 Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom
    • 7.9.6 Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the United Kingdom
  • 7.10 Japan
    • 7.10.1 Assumption and Rationale
    • 7.10.2 Incidence of Subarachnoid Hemorrhage (SAH) in Japan
    • 7.10.3 Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan
    • 7.10.4 Age-specific Incidence of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan
    • 7.10.5 WFNS Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan
    • 7.10.6 Fisher Grade wise segmentation of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan
    • 7.10.7 Clinical Manifestations of Aneurysmal Subarachnoid Hemorrhage (aSAH) in Japan

8 Appendix

9 DelveInsight Capabilities

10 Disclaimer

11 About DelveInsight